Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Secukinumab can cause hair loss, which may improve after stopping the medication.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Pranlukast and mirabegron may work as new diabetes drugs.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The baby’s hair loss was due to a rare genetic condition, not treatable by usual methods.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Hedgehog signaling helps keep hair follicle stem cells the same in both young and old human skin.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

People in Jeddah know about Vitamin D and its sources but are unclear on how much they need daily, and while many women take supplements, attitudes towards increasing Vitamin D levels vary.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Dermoscopy is useful for identifying and tracking different types of hair loss without scarring.